The Department of Health and Human Services (HHS) published in the Federal Register today that they are reopening the comment period for the June 17, 2015, proposed rule on “340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation.” Comments will be accepted on ANY aspect of the proposed rule but HHS is asking for additional comments and input in three specific areas: